Clinical CDS Focus Pro-GeneX emphasizes industry-leading clinical decision support integrated with molecular diagnostics, presenting an opportunity to upsell CDS-enabled testing programs to hospitals and health systems seeking to improve outcomes and reduce care costs.

Rapid PCR Advantage Fast 24-hour PCR results for COVID-19 and respiratory pathogens can be pitched to clinics, urgent care networks, and LTC facilities prioritizing swift clinical decisions and isolation protocols.

Pharmacogenetics Enablement PGx data integration with curated databases offers a value proposition for formulary optimization, adverse event reduction, and CMS-mandated program implementations in diverse care settings.

Toxicology Breadth Broad and fast toxicology evaluations position Pro-GeneX as a partner for hospitals and employers needing comprehensive substance testing, potential collaborations with occupational health and substance use programs.

Growth and Partnerships Revenue scale and a boutique laboratory profile suggest targeting mid-market health systems and regional players that need high-touch service, rapid turnaround, and integrated data platforms (AWS, WordPress, CRM/SEO) to scale their diagnostic services.